670-83-7

Basic information

• Product Name: 2,4-Diphenylimidazole
• Synonyms: 2,4-DIPHENYLIMIDAZOLE;2,4-Diphenyl-1H-imidazole;2,5-Diphenyl-1H-imidazole
• CAS NO: 670-83-7
• Molecular Formula: C₁₅H₁₂N₂
• Molecular Weight: 220.27
• EINECS: 1533716-785-6
• Product Categories: pharmacetical;Imidazol&Benzimidazole
• Mol File: 670-83-7.mol
• Article Data: 42

Chemical Properties

• Melting Point: 164-166 °C(Solv: ethanol (64-17-5))
• Boiling Point: 461.2 °C at 760 mmHg
• Flash Point: 254.7 °C
• Appearance: Allmost white crystal
• Density: 1.149 g/cm³
• Vapor Pressure: 3.01E-08mmHg at 25°C
• Refractive Index: 1.627
• Storage Temp.: Sealed in dry,Room Temperature
• PKA: 12.39±0.10(Predicted)
• CAS DataBase Reference: 2,4-Diphenylimidazole(CAS DataBase Reference)
• NIST Chemistry Reference: 2,4-Diphenylimidazole(670-83-7)
• EPA Substance Registry System: 2,4-Diphenylimidazole(670-83-7)

Safety Data

• Hazard Codes: Xi
• Hazardous Substances Data: 670-83-7(Hazardous Substances Data)

Usage

General Description

2,4-Diphenylimidazole is a chemical compound with the molecular formula C13H10N2. It is a white to light yellow crystalline solid that is used in a variety of industrial applications, including as a corrosion inhibitor in metalworking fluids, as a stabilizer in the production of photopolymer plates, and as a starting material for the synthesis of other pharmaceutical compounds. 2,4-Diphenylimidazole is also used as a building block in the production of dyes, pigments, and other organic compounds. It is known for its high thermal stability, which makes it suitable for use in high-temperature processes. Additionally, it is considered to have low toxicity and is not classified as a carcinogen.

InChI:InChI=1/C15H12N2/c1-3-7-12(8-4-1)14-11-16-15(17-14)13-9-5-2-6-10-13/h1-11H,(H,16,17)

Upstream product

• 92-71-7 2,5-diphenyloxazole 
• 582-24-1 1-phenyl-2-hydroxyethanone 
• 25095-48-1 2,4-diphenylpyrimidine 
• 87650-30-4 2-phenylimidazo<1,2-b><1,2>benzisothiazole 
• 7257-94-5 1-phenyl-2-(p-tolylsulfonyloxy)ethanone 
• 618-39-3 benzamidin 
• 1074-12-0 phenylglyoxal hydrate 
• 100-52-7 benzaldehyde 
• 1310-58-3 potassium hydroxide 
• 45743-05-3 2-chlorobenzimidamide 
• 70-11-1 α-bromoacetophenone 
• 39784-29-7 trans-1-(2-phenylvinyl)-5-phenyltetrazole 
• 76849-21-3 1-cyano-2,5-diphenylimidazole 
• 83576-26-5 5-phenyl-1-(1-phenylvinyl)-1H-tetrazole 

Downstream Products

• 86586-47-2 (2,5-diphenyl-1⁽³⁾H-imidazol-4-yl)-methanol 
• 143721-19-1 2,4-diphenyl-5-phenylazo-1⁽³⁾H-imidazole 
• 109277-31-8 1-methyl-2,4-diphenyl-1H-imidazole 
• 26665-84-9 2-(2,5-diphenyl-imidazol-4-ylidene)-3-methyl-5-phenyl-2,3-dihydro-[1,3,4]thiadiazole 
• 26665-85-0 2,5-diphenyl-4-(5-phenyl-[1,2]dithiol-3-ylidene)-4H-imidazole 
• 26665-83-8 2,5-diphenyl-4-(4-phenyl-[1,3]dithiol-2-ylidene)-4H-imidazole 
• 26665-82-7 2,5-diphenyl-4-(5-phenyl-[1,3]thiaselenol-2-ylidene)-4H-imidazole 
• 857271-74-0 1-ethyl-2,4-diphenyl-1H-imidazole 
• 99876-44-5 benzoyl-1 diphenyl-2,4 imidazole 

Relevant articles and documents

Structure-activity relationship studies on 2-heteroaryl-4-arylimidazoles NPY5 receptor antagonists

A series of 2-heteroaryl-4-arylimidazoles with potent in vitro activity at the NPY5 receptor was developed. Introduction of electron-withdrawing groups on the 4-aryl ring led to a significant improvement of in vitro potency. Several analogues from this series had anorectic activity in rodent feeding models, but were also found to have undesired behavioral effects in spontaneous locomotor activity.

Nickel-Catalyzed Construction of 2,4-Disubstituted Imidazoles via C–C Coupling and C?N Condensation Cascade Reactions

A convenient Ni(II)-catalyzed C?C and C?N cascade coupling reaction was developed to directly access various 2,4-disubstituted imidazoles. The reaction scope covers a variety of aryl and aliphatic substitutions, which demonstrate moderate-to-excellent yie

Rh-Catalyzed Annulation of ortho-C?H Bonds of 2-Arylimidazoles with 1,4,2-Dioxazol-5-ones toward 5-Arylimidazo[1,2-c]quinazolines

A Rh-catalyzed unique and direct approach for constructing a series of 5-arylimidazo[1,2-c]quinazolines in moderate to excellent yields from simple and readily available 2-arylimidazoles and 3-phenyl-1,4,2-dioxazol-5-ones was described. This procedure pro